Life Sciences and Healthcare M&A Advisory

We wanted to express our appreciation for the enormous contribution that the Deloitte Team made in bringing the Ashdale deal to such a successful completion. Everyone on the Deloitte Team made a really positive impact on all fronts. The success of this deal is hugely significant to MML Ireland. We would not have had this success without Deloitte as a partner and we are massively appreciative of that.

Rory Quirke

Director & Co-Head Investments, MML

Our collaboration with the unparalleled Deloitte Life Sciences Advisory Corporate team, expertly guided by the insightful Amar Shah, has exceeded all expectations and taken our success to new heights. Their unwavering commitment to providing exceptional support and guidance throughout the transaction process was instrumental in helping us secure the ideal partner with the optimal synergies to integrate OKRA.ai’s cutting-edge AI technology with Envision’s consulting capability and unique data assets, offering our customers maximum value. The Deloitte team’s deep industry knowledge and astute understanding of the buyer landscape was invaluable, proving to be the catalyst for our remarkable success. As a compact but mighty management team, we are sincerely grateful for the level of expertise and support provided by the Deloitte team, who played a crucial role in securing our success.

Loubna Bouarfa

CEO & Founder, OKRA Technologies

Deloitte demonstrated added value and managed the overall process very well, including doing significant heavy lifting. Their ability to manage complex negotiations was impressive. I’d have no hesitation in working with you again. I’d highly recommend!

Neil Cooper

Chairman & Founder, Preventx

Following a rigorous selection process, we appointed Deloitte to explore sale options for BioPhorum in early 2021. Following a number of pre-emptive bids, we concluded an accelerated sale in May 2021 which provided an exceptional outcome for all shareholders. David and Amar were both important and instrumental to Deloitte obtaining the mandate and, furthermore, provided invaluable strategic and tactical advice in a fluid and sensitive set of negotiations with BioPhorum shareholders and buyers.

Tom Chaloner

Partner, Vespa Capital & Board member, BioPhorum Group

I would like to thank the Deloitte team for the excellent support and advice they provided during this transaction. We were thoroughly impressed with their hands on approach and extensive knowledge of our sector which added real value and ensured a very smooth process.

James Gunton

Partner, Exponent & Board member, BBI Group

Their relationship management and support was second to none from big picture strategy down to the technical details. The commitment and focus they showed was unwavering. The team were very professional and they truly cared about getting the best outcome for us.

Cameron Crockett

Managing Partner, Kester Capital & Board member, Frontier Medical Group

We carried out a thorough selection process… I wanted an advisor who not only truly understood my business but who also had strong relationships with the international buyers. We have a small management team and we needed an advisor who could be patient with us but also never miss a beat on data requests. I am extremely happy that I had David and Amar negotiating for me - I couldn’t recommend the Deloitte team more highly.

Jilani Gulam

CEO, Health iQ

We chose Deloitte... based on their deep understanding of our sector... realistic, honest and practical approach... Deloitte’s team’s commitment to the Project was unwavering. The Deloitte team were always available to us and worked hard to keep all parties involved in the transaction, focused and on track. We found the whole Deloitte M&A team to be professional and hard working. They were also very patient with the management team. The end result was a very successful outcome for all stakeholders. I would have no hesitation working with Deloitte’s again and I would highly recommend them to others. 

Graeme Lee

CEO & Founder, Springfield Healthcare

The team were fantastic and on their game. Responsive, knowledgeable and effective with bidders. Solid understanding of our market space and quickly picked up the technical intricacies to effectively market our business. Effective and robust in marketing and negotiation. Hit EV expectations and delivered a transaction on expected timelines

Matt Tate

CEO, Gentronix

We are grateful to Deloitte for their unwavering support and high quality advice during such an intense process which ultimately allowed us to identify the best future partner for Vita. Their sector knowledge combined with rigorous transaction execution and stakeholder management allowed for a smooth process and very successful outcome for all stakeholders.

Robin Filmer-Wilson

Partner, Archimed

I just wanted to say a massive thank you for everything that you have done for project Dartmoor. It’s been an absolute pleasure working with you all. You’ve all been brilliant, supportive and understanding.

Emma Rooth

CEO Torbay Pharmaceuticals